Pathophysiology of dyspnea in COPD

被引:59
作者
Anzueto, Antonio [1 ,2 ]
Miravitlles, Marc [3 ,4 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Pulmonol Sect, San Antonio, TX 78229 USA
[2] South Texas Vet Hlth Care Syst, Dept Med, Pulm Sect, San Antonio, TX USA
[3] Hosp Univ Vall dHebron, Pneumonol Dept, Barcelona, Spain
[4] CIBERES, Barcelona, Spain
关键词
COPD; dyspnea; lung; bronchodilator; OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC RESPIRATORY SYMPTOMS; PATIENT-REPORTED OUTCOMES; QUALITY-OF-LIFE; LUNG HYPERINFLATION; EXERCISE TOLERANCE; PHYSICAL-ACTIVITY; STABLE COPD; FLOW LIMITATION; INDACATEROL;
D O I
10.1080/00325481.2017.1301190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dyspnea refers to the sensation of breathlessness, shortness of breath, or difficulty breathing that is commonly observed in patients with respiratory and cardiac disease. In the United States alone, dyspnea is reported in up to 4 million all-cause emergency room visits annually. Dyspnea can be a symptom of several different underlying physical conditions, typically involving the lung and heart. Indeed, it is an important symptom in chronic obstructive pulmonary disease (COPD), where it is associated with limited physical activity, increased anxiety and depression, decreased health-related quality of life (HRQoL), and reduced survival. Currently there is no single physiological correlate that will accurately predict dyspnea, particularly because the mechanisms that contribute to respiratory discomfort can vary between diseases and between individuals experiencing breathlessness who have been diagnosed with the same disease. Therefore, various subjective clinical and psychophysical scales and questionnaires are typically used to measure or predict dyspnea. It is the goal of this review to discuss the pathophysiological mechanisms leading to dyspnea, particularly those associated with COPD, the physical and psychological impact on patients, assessment approaches, and modalities currently used to treat it.
引用
收藏
页码:366 / 374
页数:9
相关论文
共 100 条
[1]   Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial [J].
Aalbers, R ;
Ayres, J ;
Backer, V ;
Decramer, M ;
Lier, PA ;
Magyar, P ;
Malolepszy, J ;
Ruffin, R ;
Sybrecht, GW .
EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (05) :936-943
[2]  
[Anonymous], 2015, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD010139
[3]   Assessing COPD profiles and outcomes by dyspnoea severity [J].
Anzueto, Antonio R. ;
Calverley, Peter M. A. ;
Wise, Robert A. ;
Mueller, Achim ;
Metzdorf, Norbert ;
Dusser, Daniel .
EUROPEAN RESPIRATORY JOURNAL, 2016, 48
[4]   The dyspnea-anxiety-dyspnea cycle - COPD patients' stories of breathlessness: "It's scary/when you can't breathe" [J].
Bailey, PH .
QUALITATIVE HEALTH RESEARCH, 2004, 14 (06) :760-778
[5]   The affective dimension of laboratory dyspnea: Air hunger is more unpleasant than work/effort [J].
Banzett, Robert B. ;
Pedersen, Sarah H. ;
Schwartzstein, Richard M. ;
Lansing, Robert W. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (12) :1384-1390
[6]   Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research [J].
Banzett, Robert B. ;
O'Donnell, Carl R. ;
Guilfoyle, Tegan E. ;
Parshall, Mark B. ;
Schwartzstein, Richard M. ;
Meek, Paula M. ;
Gracely, Richard H. ;
Lansing, Robert W. .
EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (06) :1681-1691
[7]   Dual bronchodilation with QVA149 versus single bronchoditator therapy: the SHINE study [J].
Bateman, Eric D. ;
Ferguson, Gary T. ;
Barnes, Neil ;
Gallagher, Nicola ;
Green, Yulia ;
Henley, Michelle ;
Banerji, Donald .
EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (06) :1484-1494
[8]   Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial [J].
Beeh, Kai M. ;
Singh, Dave ;
Di Scala, Lilla ;
Drollmann, Anton .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 7 :503-513
[9]   Effect of Indacaterol on Dynamic Lung Hyperinflation and Breathlessness in Hyperinflated Patients with COPD [J].
Beeh, Kai-Michael ;
Wagner, Frank ;
Khindri, Sanjeev ;
Drollmann, Anton Franz .
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2011, 8 (05) :340-345
[10]   Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase IIIb Study [J].
Beier, Jutta ;
Kirsten, Anne-Marie ;
Mroz, Robert ;
Segarra, Rosa ;
Chuecos, Ferran ;
Caracta, Cynthia ;
Garcia Gil, Esther .
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 10 (04) :511-522